Projects - The Health Policy Partnership

Transforming lung cancer care

HPP worked with the International Association for the Study of Lung Cancer (IASLC) to identify opportunities for policy action to improve the lives of people with lung cancer.

View Project

Optimising care for chronic hepatitis B

HPP has convened a multidisciplinary Steering Committee of international experts to develop a clear case for improving hepatitis B care, including the best route to achieve this.

View Project

Lung Cancer Policy Network

HPP acts as secretariat to the Lung Cancer Policy Network, a global multidisciplinary alliance that aims to make lung cancer an international policy priority.

View Project

Immunisation for people living with non-communicable diseases

Immunisation against common respiratory infections is a crucial tool for reducing the burden of NCDs.

View Project

Chronic respiratory diseases

Chronic respiratory diseases, which affect the airways and lungs, impede the lives of over 454 million people worldwide.

View Project

Building environmental considerations into the evaluation of health interventions

HPP worked with the Sustainable Healthcare Coalition to develop a discussion paper on building environmental consideration into the evaluation of health interventions.

View Project

National calls to action for radioligand therapy

Radioligand therapy is a targeted treatment with huge potential to improve cancer care around the world; HPP collaborated with experts to identify key barriers to implementing radioligand therapy and co-developed recommendations to overcome these challenges.

View Project

Meeting the needs of people with pulmonary arterial hypertension

Pulmonary arterial hypertension (PAH) is a rare and progressive form of pulmonary hypertension that causes narrowing of the blood vessels in the lungs; if left untreated, PAH leads to heart failure, with high rates of hospitalisations and death.

View Project

Committing to cholesterol management in England

HPP supported multidisciplinary experts to produce a vision for change in cholesterol management as part of holistic cardiovascular disease prevention in England.

View Project

Health system readiness for radioligand therapy

HPP developed an international framework to assess health system readiness for radioligand therapy, an innovative cancer treatment.

View Project

Building readiness for precision cancer medicine through clinical trials

HPP and Testbed Sweden have developed a framework to help researchers design and run trials that support integration of precision cancer medicine in practice.

View Project

Reducing inequalities in metastatic breast cancer care

Metastatic breast cancer affects millions of people and accounts for the vast majority of breast cancer deaths, and inequalities in care are increasing.

View Project

Preventing RSV in infants

HPP developed a policy report, framework and associated resources to support the implementation of innovative strategies to protect all infants from respiratory syncytial virus (RSV).

View Project

The state of COPD

COPD is a highly debilitating and often fatal lung disease, and is one of the leading causes of death worldwide.

View Project

Advanced cancer diagnostics

HPP developed a report detailing the potential of advanced diagnostics to transform outcomes for people with cancer.

View Project

The Heart Failure Policy Network

HPP acts as secretariat to the Heart Failure Policy Network, a multidisciplinary network working to raise awareness of the unmet needs of people with heart failure across Europe.

View Project

Wilson’s Disease Policy Network

The Wilson’s Disease Policy Network is a European multidisciplinary alliance that aims to drive greater awareness, momentum and engagement from policymakers.

View Project

A Million Conversations

HPP produced an international policy report with an international expert advisory group on building trust between people from traditionally under-represented groups and their healthcare providers in order to achieve more inclusive health systems and improve health outcomes.

View Project

Severe asthma

Asthma is a common and generally mild condition, but 3–10% of people with asthma have severe asthma, a distinct condition in which they experience repeated, uncontrollable and life-threatening asthma attacks.

View Project

Achieving early detection and diagnosis of cardiovascular disease

HPP supported Global Heart Hub in the development of a manifesto for the early detection and diagnosis of cardiovascular disease

View Project

Transitioning to electronic product information (ePI)

Digital-first presentation of medicine information could address the accessibility and environmental issues of the current paper-based system.

View Project

Exploring the evolving role of cloud technology in healthcare

HPP partnered with experts to develop an accessible report outlining what cloud technology is and its potential to enable transformation across health systems.

View Project

Lung cancer in Europe: accelerating opportunities to improve survival

HPP co-hosted a webinar exploring ways to improve lung cancer survival in Europe.

View Project

Hidradenitis suppurativa

HPP collaborated with patient representatives and clinicians to raise awareness of hidradenitis suppurativa and its wide-ranging effects on quality of life.

View Project

Manifesto for the future of cardiomyopathy care

HPP supported the International Cardiomyopathy Network (ICoN) in formulating a shared vision to drive change for cardiomyopathy

View Project

Shared decision-making for people with heart valve disease

HPP collaborated with the Global Heart Hub to develop patient resources to support guideline‑recommended shared decision‑making

View Project

Overcoming Europe’s nursing workforce crisis

HPP collaborated with nursing organisation representatives to explore some of the major challenges faced by the nursing workforce in the context of an increasing burden of non-communicable diseases.

View Project

Investing in primary care for diabetes

HPP developed materials that set out the need for policymakers to invest in primary care to improve diabetes outcomes and reduce the economic burden of the disease.

View Project

Patient care pathway for neuroendocrine cancer

HPP collaborated with Neuroendocrine Cancer UK to develop an ideal patient care pathway for people living with neuroendocrine cancer in England.

View Project

Building equity in clinical trials

HPP produced a policy report exploring the barriers to equitable, diverse and inclusive clinical trials for metastatic breast cancer and highlighting opportunities to improve practice.

View Project